All News


All series


All All News

Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen.

An injured cancer survivor reluctantly but gratefully copes with neuropathy, osteopenia and stiff-joint cancer side effects after recently breaking her foot and getting surgery.

A higher percentage of body fat – specifically fat in the abdominal area – was associated with an increased risk of certain cancers for postmenopausal women, according to a recent study presented at the 2017 European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.